Beijing Golden Key Gene Technology Co.
Latest round
- Series C
Last raised
- Jun 2021
Total raised
- $56M
Investors
- 11
About Beijing Golden Key Gene Technology Co.
, Ltd. is a medical company that focuses on clinical diagnosis based on gene technology. In 2017, the company changed its name from Beijing Golden Key Medical Technology to Beijing Golden Key Biological Technology., Ltd. In 2019, it launched a respiratory infection diagnostic product. The company has a subsidiary called Golden Key Zhizao. Ms. Zhi Jiang, the founder and CEO of the company, served as the director of BGI Gene Technology Service Division and the president of Nuohe Zhiyuan. The company engages in the research and development of pathogenic diagnostic products. Its main products include the COVID-19 detection product series and the pathogen metagenomic product series. The company also provides testing services for the COVID-19 and metagenomics. The company's products are used in hospitals and medical laboratories.
Who invested in Beijing Golden Key Gene Technology Co.
11 investors across 6 rounds
See all investors in Beijing Golden Key Gene Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Questions about Beijing Golden Key Gene Technology Co.
Who invested in Beijing Golden Key Gene Technology Co.?
Beijing Golden Key Gene Technology Co. has 11 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Golden Key Gene Technology Co. raised?
Beijing Golden Key Gene Technology Co. has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Beijing Golden Key Gene Technology Co. last raise money?
Beijing Golden Key Gene Technology Co.'s most recent round on record is a Series C, in Jun 2021.
What does Beijing Golden Key Gene Technology Co. do?
Beijing Golden Key Gene Technology Co. is a biotechnology company.
Where is Beijing Golden Key Gene Technology Co. headquartered?
Beijing Golden Key Gene Technology Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing Golden Key Gene Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beijing Golden Key Gene Technology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Beijing Golden Key Gene Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.